Number of pages: 100 | Report Format: PDF | Published date: November 10, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
The global metagenomics market was pegged at US$ 1.5 billion in 2021 and is expected to witness a CAGR of 17% during the forecast period.
The study of a collection of genomes from a diverse group of organisms is known as metagenomics. Typically, the term "metagenomics" relates to the study of microbial communities. For metagenomics sequencing, platforms for genomic analysis are becoming more and more common. Analysing genes and researching metabolic pathways are the main goals of a metagenomics research. New industrial and therapeutic products derived from the environment are investigated using metagenomics. It focuses on the analysis of the taxonomy and composition of microbial cultures. Three types of goods are sold on the metagenomics market: kits for preparing libraries, extracting samples, and sequencing metagenomic data. The entire genome is separated from its surroundings, broken up, and finally sequenced.
Metagenomic sequencing systems have made great progress in recent years thanks to technological breakthroughs. DNA sequencing is significantly more useful and advantageous than conventional microarrays because of a number of characteristics, including the minimal input sample concentration requirements, the lack of experimental bias in microarrays, and others. The introduction of enormous parallelization of sequencing operations has caused a dramatic increase in the overall number of sequences reads produced per run.
The global metagenomics market has been analyzed from four perspectives by technology, product, application and region.
Metagenomics Market by Technology
Based on technology, the global metagenomics market has been segmented into sequencing and bioinformatics. The sequencing segment dominated the market during forecast period. For their genetic study, many academic institutions and research facilities are utilising technology. For instance, in July 2022, according to a report on the Arthritis & Rheumatology site, the genetic background and disease activity have an impact on the gut microbiota's makeup. Shotgun sequencing was used in the study to get this result.
Metagenomics Market by Product
Based on product, the global metagenomics market has been segmented into instruments, kits and reagents and consumables. The consumables segment dominated the market during forecast period, and it is anticipated that it will continue to dominate during the projection period. The predominance of this market sector has been attributed to the high adoption of consumables in pre-sequencing, one of the most crucial processes in the total metagenomic sequencing protocol. Additionally, by making the most of the available resources, the DNA used in the metagenomic study will be representative of all the cells in the sample and suitable for creating genomic libraries.
Metagenomics Market by Application
Based on application, the global metagenomics market has been segmented into infectious disease diagnosis, environmental remediation, gut microbe characterized, human health, biotechnology, biofuel, and agriculture. Throughout the forecast period, the gut microbe characterisation segment is anticipated to continue to dominate the global market. Human health is significantly influenced by the homeostatic environment of the gut microbiota, and when this balance is upset, it makes people more vulnerable to infections from different pathogens. Furthermore, the segment for diagnosing infectious diseases is anticipated to increase at the fastest rate. This is explained by the growing use of metagenomic technologies among clinical researchers, which facilitates the detection of bacterial pathogens in charge of a number of infectious disorders.
Metagenomics Market by Region
Based on region, the global metagenomics market has been segmented into North America, Europe, Asia Pacific, and Rest of the world. The market for metagenomic sequencing was controlled by North America. This is primarily due to encouraging government and private sector initiatives for the development and adoption of NGS-based metagenomics technologies, the widespread use of metagenomic diagnostics in the region, an increase in the number of NGS-based metagenomics research and clinical applications in the region and growing public awareness of metagenomics sequencing services. The Asia-Pacific region is anticipated to see the greatest CAGR during the projection period. Additionally, during the forecast period, Europe will be another lucrative market with a significant market share. The growth potential has been spurred by the increased use of bioinformatics technologies. Furthermore, persistent study of soil diversity and microbial ecology has sped up the use of metagenomics, boosting the market's revenue potential.
Some of the prominent market player in the global metagenomics include
The Asia Pacific is the key growth region in the global metagenomics market
The rise in technological developments that led to the development of sequencing instruments.
The global metagenomics market is expected to clock US$ 6.16 billion by 2030
The global metagenomics market is expected to witness a CAGR of 17% during the forecast period.
Some of the prominent market player in the global metagenomics includecBio-Rad Laboratories, Illumina, Inc., PerkinElmer, Inc., Swift Biosciences Inc., Thermo Fisher Scientific and others.
*Insights on financial performance is subject to availability of information in public domain